Data as of Apr 15
| +0.10 / +7.63%|
The 1 analysts offering 12-month price forecasts for LifeVantage Corp have a median target of 2.10, with a high estimate of 2.10 and a low estimate of 2.10. The median estimate represents a +48.94% increase from the last price of 1.41.
The current consensus among 2 polled investment analysts is to Buy stock in LifeVantage Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.